Suraksha Diagnostic informs about resignation of chief financial officer (CFO)

02 Mar 2026 Evaluate
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, Suraksha Diagnostic has informed that the Company has received a letter from K S Ravindra on 02 March 2026, tendering his resignation from the position of Group Chief Financial Officer (CFO) designated as Key Managerial Personnel (KMP) of the Company. His last working day with the Company would be on or before 31 May 2026 (close of business hours). The Company places on record its deep sense of appreciation for the services rendered by K S Ravindra and for his contribution during his tenure as the Group CFO of the Company. The detailed disclosure as required under Regulation 30 read with Schedule III- Para A (7C) of Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026 is enclosed as ‘Annexure-A’. Further, the Company has received confirmation from K S Ravindra, that there are no material reasons for his resignation other than those mentioned in his resignation letter, which is enclosed as ‘Annexure-B’. Further noted that this information shall also be made available on the website of the Company at www.surakshanet.com.

The above information is a part of company’s filings submitted to BSE.

Suraksha Diagnostic Share Price

259.25 -8.25 (-3.08%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7722.95
Max Healthcare Inst 1042.70
Narayana Hrudayalay 1754.55
Aster DM Healthcare 672.95
Global Health 1109.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×